JEAN MICHEL BRUNEL | Microbiology | Research Excellence Award

Published on by Molecular Biologist

Dr. Jean Michel Brunel | Microbiology | Research Excellence Award

CRHC | Faculty of Pharmacy | France

Dr. Jean Michel Brunel is a distinguished French chemist whose research focuses on organic synthesis, medicinal chemistry, and antimicrobial drug discovery. As a senior CNRS Researcher and group leader at Aix-Marseille Université, he leads a team developing antibiotic adjuvants, polyamine derivatives, and next-generation antimicrobial agents. His work integrates medicinal chemistry, microbiology, and organoselective synthesis to create therapeutic probes and drug prototypes that target bacterial pathways, disrupt biofilms, and enhance antibiotic efficacy against multi-drug-resistant bacteria, including Pseudomonas aeruginosa. Brunel’s research spans natural product chemistry, synthetic scaffolds, and bile acid analogues, extending from in vitro screening to in vivo models to ensure translational impact. Supported by major research grants, international collaborations, and industrial partnerships, his efforts advance the development of innovative anti-infective therapies. His prolific output includes 235 publications cited over 7,700 times across more than 6,200 documents, with an h-index of 42, reflecting his significant influence on global antimicrobial research and drug discovery.

Profiles: Scopus | ORCID | Google Scholar

Featured Publications

Permeabilize, but choose wisely: Selective antibiotic potentiation through outer membrane disruption in Pseudomonas aeruginosa. International Journal of Molecular Sciences.

Adaptation to cinnamaldehyde shapes Pseudomonas aeruginosa resistance to major antibiotics. Journal of Bacteriology.

Accurate antibiotic accumulation in Enterobacteriaceae isolates expressing efflux pumps. Biochimica et Biophysica Acta Biomembranes.

Don’t miss out on new publications by this author!

Bioinspired syntheses of the marine pyridoacridine alkaloids 2-Bromo and 3-Bromodeoxyamphimedine and structure correction of 2-Bromoamphimedine. Journal of Natural Products.

Efflux-mediated resistance in Enterobacteriaceae: Recent advances and ongoing challenges to inhibit bacterial efflux pumps.

Uric acid, the end-product of purine metabolism, mitigates tau-related abnormalities: Comparison with DOT, a non-antibiotic oxytetracycline derivative. Biomolecules.

 

Alaa Niamah | Microbiology | Best Researcher Award

Published on by Molecular Biologist

Prof. Dr. Alaa Niamah | Microbiology | Best Researcher Award 

Professor of Microbiology | University of Basrah | Iraq

Prof. Dr. Alaa Kareem Niamah is a Professor of Dairy Microbiology at the University of Basrah, Iraq, recognized for his extensive research in food microbiology, probiotics, bacteriocins, and dairy biotechnology. With more than twenty years of academic and research experience, he has contributed significantly to the development of functional foods, natural antimicrobial agents, and advanced fermentation technologies. His scientific impact is reflected in 1,038 citations across 929 documents, supported by 47 published documents and an h-index of 17. Dr. Niamah’s work addresses microbial interactions, food safety, enzymatic activity, and the optimization of dairy and plant-based fermentation systems. He has collaborated with international institutions, supervised postgraduate research, and served on editorial boards, scientific committees, and conference panels in multiple countries. Through his interdisciplinary approach to microbial biotechnology and dairy science, he continues to advance innovative solutions for food quality, safety, and sustainable production.

Profiles: Scopus | ORCID | Google Scholar

Featured Publications

Management of agri-food wastes via novel biotechnological methods: Emerging trends and technological advances. In Editor1, E. E. (Ed.)

 Applications of green synthesis of nanoparticles using microorganisms in food and dairy products: A review. Journal Name, Volume(Issue)

Immunomodulation capability and cytotoxicity activities of novel exopolysaccharides produced by a new local strain, Bifidobacterium longum subsp. infantis strain Iraq-Basrah 3. Journal of Applied Biology and Biotechnology, Volume(Issue),

Exploring the chemistry and sources of microbial 1,2-propanediol (propylene glycol) with a focus on biosynthesis, extraction, and identification for nutraceutical significance and human health. In Editor1, E. E. (Ed.)

Getachew Alamnie | Microbiology | Editorial Board Member

Published on by Molecular Biologist

Assist Prof Dr. Getachew Alamnie | Microbiology | Editorial Board Member 

Researcher | Mekdela Amba University | Ethiopia

Dr. Getachew Alamnie is an Ethiopian researcher whose work spans molecular biology, biotechnology, nanotechnology, and microbial bioprocessing. His contributions include important findings on the association between Vitamin D deficiency, VDR FokI gene polymorphisms, and diabetic retinopathy complications in Ethiopian patients with type 2 diabetes. In biotechnology, he has advanced microbial enzyme applications through the production of keratinase from Bacillus subtilis GH2 for sustainable feather biodegradation. Dr. Alamnie also contributes extensively to nanoscience, co-authoring impactful studies on the antibacterial properties of metallic nanoparticles and green-synthesized silver nanoparticles designed to combat multidrug-resistant bacteria. His research further extends to agricultural biotechnology, especially the use of CRISPR/Cas9-mediated genome editing to enhance crop resilience against abiotic stress. He has additionally explored innovative bioprocessing strategies, including the use of chicken feather protein hydrolysate as an affordable peptone source for microbial cultivation. With 17 citations across 14 documents, 7 published papers, and an h-index of 3, Dr. Alamnie’s growing scholarly influence reflects his strong multidisciplinary contributions to health, agriculture, and environmental sustainability.

Profiles: Scopus | ORCID

Featured Publications

Melake, A., Alamnie, G., & Mekonnen, M. Association of vitamin D deficiency and vitamin D receptor FokI gene polymorphism with diabetic retinopathy complications in Ethiopian patients with type 2 diabetes mellitus. International Journal of Immunogenetics.

Girma, A., Mebratie, G., Mekuye, B., Abera, B., Bekele, T., & Alamnie, G. Antibacterial capabilities of metallic nanoparticles and influencing factors. Nano Select.

Adane, M., & Alamnie, G. CRISPR/Cas9 mediated genome editing for crop improvement against abiotic stresses: Current trends and prospects. Functional & Integrative Genomics.

Alamnie, G. Production of keratinase enzyme from B. subtilis GH2 and its application in feather biodegradation. Biomass Conversion and Biorefinery.

Ohad Gal-Mor | Microbiology | Best Researcher Award

Published on by Molecular Biologist

Prof. Dr. Ohad Gal-Mor | Microbiology | Best Researcher Award 

Head the Infectious Diseases Research Laboratory | TAU and Sheba Medical Center | Israel

Prof. Dr. Ohad Gal-Mor is a distinguished microbiologist and academic leader specializing in infectious diseases and bacterial pathogenesis. He is Head of the Infectious Diseases Research Laboratory at Sheba Medical Center and a Full Professor in the Department of Clinical Microbiology and Immunology at Tel Aviv University. His research has significantly advanced the understanding of Salmonella virulence, persistence, and host adaptation. He has also contributed to the study of antimicrobial resistance and bacterial evolution, bridging fundamental microbiology with global public health. In addition to his scientific achievements, Prof. Gal-Mor has held influential leadership positions, including Director of the Nehemia Rubin Program for Excellence in Biomedical Research and Chair of the Biomedical Academic Research Institute at Sheba Medical Center. Through his research, teaching, and mentorship, he has shaped the careers of many young scientists and continues to contribute to advancing knowledge in microbiology and infectious diseases worldwide.

Professional Profile

Scopus

ORCID

Google Scholar

Education

Prof. Dr. Ohad Gal-Mor pursued his academic training at Tel Aviv University, where he developed a strong foundation in molecular microbiology and life sciences. He obtained a Bachelor of Science in Biology at the Faculty of Life Sciences, focusing on core areas of biological and molecular systems. Following this, he was accepted into a prestigious direct-track doctoral program, earning his Ph.D. in Molecular Microbiology from the Department of Molecular Microbiology and Biotechnology. His doctoral research was dedicated to exploring microbial genetics and the mechanisms of host-pathogen interactions, providing the groundwork for his later contributions to bacterial pathogenesis. This rigorous training prepared him for postdoctoral research in Canada, where he worked with world-leading scientists and refined his expertise in host-pathogen studies. His educational background reflects both scientific rigor and an interdisciplinary approach, equipping him with the tools to investigate complex questions of microbial evolution, infection biology, and molecular regulation.

Experience

Prof. Dr. Ohad Gal-Mor has an extensive record of academic and research leadership in microbiology. After earning his Ph.D., he pursued postdoctoral research at the University of British Columbia in Canada, focusing on host-pathogen interactions in the laboratory of Professor Brett Finlay. He then advanced to a Research Associate role at the same institution before returning to Israel, where he became Director of the Enterobacteriaceae National Center at the Ministry of Health. Since then, he has established and led the Infectious Diseases Research Laboratory at Sheba Medical Center, driving innovation in infectious disease research. At Tel Aviv University, he progressed from Senior Lecturer to Associate Professor and is now a Full Professor. He has served as Secretary of the Israel Society for Microbiology and Section Editor for the journal Virulence. His professional journey highlights an exceptional blend of academic scholarship, research leadership, and international collaboration.

Research Interests

Prof. Dr. Ohad Gal-Mor’s research focuses on microbial pathogenesis, host-pathogen interactions, and bacterial evolution. His studies primarily investigate Salmonella enterica, with particular emphasis on genetic diversity, antimicrobial resistance, and adaptation to host environments. He explores how horizontally acquired elements, plasmids, and regulatory pathways contribute to virulence and persistence in both human and animal hosts. By integrating molecular biology, microbiology, and genomics, his group uncovers mechanisms that allow bacteria to survive within hosts, evade immune responses, and adapt to different ecological niches. He also investigates the emergence and spread of multidrug-resistant strains, addressing pressing issues in public health. His use of genomic sequencing, transcriptomics, and advanced infection models ensures that his research remains at the forefront of modern microbiology. Ultimately, his work aims to inform the development of novel antimicrobial strategies, vaccines, and prevention approaches, advancing both fundamental science and translational medicine.

Awards and Recognition

Prof. Dr. Ohad Gal-Mor has received recognition for his research excellence and leadership in the field of microbiology. His publication in PLoS Pathogens was highlighted as the Featured Image of the Month and selected as Paper of the Month by the German Society of Hygiene and Microbiology, showcasing his international impact. He has served in leadership roles such as Secretary of the Israel Society for Microbiology and Director of the Nehemia Rubin Program for Excellence in Biomedical Research at Sheba Medical Center, reflecting his dedication to advancing both science and education. His appointment as Chair of the Biomedical Academic Research Institute demonstrates the trust placed in his leadership within Israel’s largest medical center. These honors highlight his contributions not only as a researcher but also as a mentor and leader, recognized nationally and internationally for advancing the study of bacterial pathogenesis and infectious diseases.

Top Noted Publications

Prof. Dr. Ohad Gal-Mor has published extensively in leading international journals, making significant contributions to bacterial pathogenesis and antimicrobial resistance research. Selected publications include:

Title: The transcriptional regulation of the horizontally acquired iron uptake system, yersiniabactin and its contribution to oxidative stress tolerance and pathogenicity of globally emerging salmonella strains.
Journal: Gut Microbes
Year: 2024

Title: Persistent Salmonella infections in humans are associated with mutations in the BarA/SirA regulatory pathway.
Journal: Cell Host & Microbe
Year: 2024

Title: A new Salmonella enterica serovar that was isolated from a wild sparrow presents a distinct genetic, metabolic and virulence profile.
Journal: Microbes and Infection
Year: 2024

Title: The emergence of a multidrug resistant Salmonella Muenchen in Israel is associated with horizontal acquisition of the epidemic pESI plasmid.
Journal: Clinical Microbiology and Infection
Year: 2022

Title: Intracellular Salmonella Paratyphi A is motile and differs in the expression of flagella-chemotaxis, SPI-1 and carbon utilization pathways in comparison to intracellular S. Typhimurium.
Journal: PLoS Pathogens
Year: 2022

Title: The ancestral stringent response potentiator, DksA has been adapted throughout Salmonella evolution to orchestrate the expression of metabolic, motility, and virulence pathways.
Journal: Gut Microbes
Year: 2022

Title: Pathoadaptation of the passerine-associated Salmonella enterica serovar Typhimurium lineage to the avian host.
Journal: PLoS Pathogens
Year: 2021

Title: Emergence of new variants of antibiotic resistance genomic islands among multidrug-resistant Salmonella enterica in poultry.
Journal: Environmental Microbiology
Year: 2020

Title: The plasmid-encoded Ipf and Klf fimbriae display different expression and varying roles in the virulence of Salmonella enterica serovar Infantis in mouse vs. avian hosts.
Journal: PLoS Pathogens
Year: 2017

Conclusion

Prof. Dr. Ohad Gal-Mor stands out as a highly suitable nominee for the Best Researcher Award. His work addresses critical challenges in global health, particularly the rise of antibiotic resistance and the evolution of bacterial pathogens, issues of major concern for both science and society. His scientific rigor, combined with international recognition and leadership, justifies his candidacy as an exemplary researcher whose contributions have advanced the frontiers of microbiology and infectious disease research.

Nadia Jaidane | Microbiology | Women Researcher Award

Published on by Molecular Biologist

Dr. Nadia Jaidane | Microbiology | Women Researcher Award

Postdoctoral researcher, at Faculty of medecine Sousse, Tunisia.

🌟 Dr. Nadia Jaidane is a distinguished microbiologist specializing in pharmaceutical sciences. Born on September 17, 1976, in Tunisia, she has made significant contributions to the field of clinical microbiology and bacterial resistance research. With over two decades of experience, she is currently a Professor of Paramedical Education at the Higher School of Health Sciences and Techniques of Monastir. Her research focuses on antimicrobial resistance, hospital hygiene, and infectious diseases, contributing to numerous scientific publications and international collaborations. She actively participates in scientific congresses and professional organizations, reinforcing her expertise in the field.

Professional Profile

Scopus

ORCID

Education

🎓 Dr. Jaidane holds a Ph.D. in Pharmaceutical Sciences, specializing in Microbiology, awarded with “Very Honourable Distinction” from the Faculty of Pharmacy of Monastir, Tunisia, in collaboration with the University of Paris-Sud. She also holds multiple master’s degrees in hospital hygiene, food quality and bioprocesses, and life and earth sciences, all obtained with honors. Additionally, she has a Graduate Diploma in Medical Biology and a Complementary Diploma in Medical Pedagogy from Faculty of Medicine Ibn El Jazzar – Sousse. Her diverse academic background equips her with expertise in microbiology, medical education, and quality management in healthcare.

Experience

💼 Dr. Jaidane has held several key roles in academia and healthcare. Since 2013, she has been a Professor of Paramedical Education, training students in medical biology. Previously, she served as a Hygienist Technician at the Department of Prevention and Security of Care at Sahloul University Hospital, where she contributed to infection control and hospital hygiene. She also worked as an Epidemiologist Technician and a Sleep/Neurodiagnostic Technician, demonstrating her versatility in medical sciences. Her extensive experience bridges research, clinical practice, and education in microbiology and public health.

Research Interests

📚 Dr. Jaidane’s research interests focus on antimicrobial resistance, infectious diseases, and hospital hygiene. She has conducted genomic studies on resistant bacterial strains, particularly Klebsiella pneumoniae and Acinetobacter baumannii, contributing to the understanding of bacterial resistance mechanisms. Her work also explores epidemiological trends in nosocomial infections and antibiotic consumption patterns in healthcare settings. Through her research, she aims to develop strategies for controlling and preventing bacterial infections in hospitals, thereby improving patient safety and public health outcomes.

Awards & Recognitions

🏆 Dr. Jaidane has received multiple honors throughout her career. She earned “Very Honourable Distinction” for her Ph.D. and “Honors” in all her master’s degrees. She has been an active member of scientific congresses, contributing to the advancement of microbiology and hospital hygiene. Additionally, she has played a pivotal role in several epidemiological studies on infection control, receiving recognition for her contributions to healthcare safety and antimicrobial resistance research.

Top Noted Publications

📚 Dr. Jaidane has authored multiple peer-reviewed publications in high-impact journals, including:

  • Genomic analysis of in vivo acquired resistance to colistin and rifampin in Acinetobacter baumannii

    • Journal: International Journal of Antimicrobial Agents, 2018

    • Citations: 50+

    • Summary: This study investigates genetic mechanisms underlying colistin and rifampin resistance in A. baumannii through whole-genome sequencing. It identifies mutations contributing to resistance development during treatment.

  • Genomic Insights into Colistin-Resistant Klebsiella pneumoniae

    • Journal: Antimicrobial Agents and Chemotherapy, 2018

    • Citations: 40+

    • Summary: This paper explores genetic adaptations in K. pneumoniae strains resistant to colistin, revealing mutations in genes associated with lipid A modification and efflux pumps.

  • Whole genome sequencing of NDM-1-producing ST85 Acinetobacter baumannii

    • Journal: International Journal of Antimicrobial Agents, 2018

    • Citations: 35+

    • Summary: The study characterizes A. baumannii ST85 strains harboring the NDM-1 carbapenemase gene, highlighting their genomic features and resistance determinants.

  • Temporal Variation in Antibiotic Resistance of Acinetobacter baumannii

    • Journal: The Open Microbiology Journal, 2019

    • Citations: 20+

    • Summary: This research analyzes the changing patterns of antibiotic resistance in A. baumannii over time, providing insights into epidemiological trends and resistance evolution.

  • Epidemiology of resistance and phenotypic characterization of carbapenem resistance

    • Journal: African Health Sciences, 2019

    • Citations: 15+

    • Summary: The study describes the epidemiology and resistance mechanisms of carbapenem-resistant bacteria, emphasizing phenotypic and molecular characterization.

  • Ten golden rules for optimal antibiotic use in hospital settings

    • Journal: World Journal of Emergency Surgery, 2023

    • Citations: 10+

    • Summary: This paper outlines key principles for antimicrobial stewardship in hospitals, aiming to reduce resistance development and improve patient outcomes.

Conclusion

Dr. Nadia Jaidane is a highly qualified candidate with a strong research portfolio in microbiology and antimicrobial resistance. Her extensive academic background, impactful publications, and active engagement in the scientific community make her a strong contender. To maximize her chances, demonstrating leadership in grant-funded projects, winning more international awards, and emphasizing research impact on public health policy would further strengthen her application.